High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome

Medicine

Volumn 82, Issue 1, 2003, Pages 27-38

  Coppo, Paul ^a,b,d   Bussel, Annette ^b   Charrier, Sabine ^a   Adrie, Christophe ^b   Galicier, Lionel ^b   Boulanger, Emmanuelle ^b   Veyradier, Agnés ^c   Leblanc, Thierry ^b   Alberti, Corinne ^b   Azoulay, Elie ^b   Le Gall, Jean Roger ^b   Schlemmer, Benoît ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c HÔPITAL ANTOINE BÉCLÈRE   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; COLLAPSE; CONTROLLED STUDY; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; INFECTION; MALE; MORTALITY; PLASMA TRANSFUSION; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; REMISSION; RETROSPECTIVE STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PLASMA; PLASMA EXCHANGE; PURPURA, THROMBOTIC THROMBOCYTOPENIC; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0037250139     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005792-200301000-00003     Document Type: Article

References (34)

1. Bell WR, Braine HG, Ness PM, Kichler TS. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med 325: 398-403, 1991.
2. Byrnes JJ, Khurana M. Treatment of thrombotic thrombocytopenic purpura with plasma. N Engl J Med 297: 1386-9, 1977.
3. Coppo P, Lassoued K, Mariette X, Gossot D, Oksenhendler E, Adrie C, Azoulay E, Schlemmer B, Clauvel JP, Bussel A. Effectiveness of platelet transfusion after plasma exchange in adult thrombotic thrombocytopenic purpura: A report of two cases. Am J Hematol 68: 198-201, 2001.
4. De la Rubia J, Lopez A, Arriaga F, Cid AR, Vicente AI, Marty ML, Sanz MA. Response to plasma exchange and steroids as combined therapy for patients with thrombotic thrombocytopenic purpura. Acta Haematol 102: 12-6, 1999.
5. Dervenoulas J, Tsirigotis P, Bollas G, Pappa V, Xiros N, Economopoulos T, Pappa M, Mellou S, Kostourou A, Papageorgiou E, Raptis SA. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): Treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases. Ann Hematol 79: 66-72, 2000.
6. Dundas S, Murphy J, Soutar RL, Jones GA, Hutchinson SJ, Todd WTA. Effectiveness of therapeutic plasma exchange in the 1996 Lanarkshire Escherichia coli O 157:H7 outbreak. Lancet 354: 1327-30, 1999.
7. Eddy AA, Geary DF, Balfe JW, Clark WF, Baumal R. Prolongation of acute renal failure in two patients with hemolytic-uremic syndrome due to excessive plasma infusion therapy. Pediatr Nephrol 3: 420-3, 1989.
8. Fakhouri F, Vincent F, Legendre C. Pathological and therapeutic distinction in HUS/TTP [Correspondence]. Lancet 355: 497-8, 2000.
9. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lammle B. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339: 1578-84, 1998.
10. Furlan M, Robles R, Morselli B, Sandoz P, Lammle B. Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombocytic thrombocytopenic purpura. Thromb Haemost 81: 8-13, 1999.
11. George JN. How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Blood 96: 1223-9, 2000.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-81, 1958.
13. Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, Yang AY, Siemieniak DR, Stark KR, Gruppo R, Sarode R, Shurin SB, Chandrasekaran V, Stabler SP, Sabio H, Bouhassira EE, Upshaw JD Jr, Ginsburg D, Tsai HM. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413: 488-94, 2001.
14. Mantel N, Haenszel W. Statistical aspect of the analysis of data from retrospective studies of disease. J Natl Cancer Instit 22: 719-48, 1959.
15. McLaine PN, Marks MI, Baliah T, Drummond KN. Hyperproteinemic proteinuria induced by plasma infusion. Pediatr Res 3: 597-603, 1969.
16. Moake JL, Rudy CK, Troll JH, Schafer AI, Weinstein MJ, Colannino NM, Hong SL. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 307: 1432-5, 1982.
17. Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Hellums JD. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest 78: 1456-61, 1986.
18. Novitzky N, Jacobs P, Rosenstranch W. The treatment of thrombotic thrombocytopenic purpura: Plasma infusion or exchange? Br J Haematol 87: 317-20, 1994.
19. Patton JF, Manning KR, Case D, Owen J. Serum lactate deshydrogenase and platelet count predict survival in thrombotic thrombocytopenic purpura. Am J Hematol 47: 94-9, 1994.
20. Petrie JJ, Cleland JF, MacLean PR, Robson JS. Glomerular permeability during proteinuria induced by plasma infusion. Clin Sci 39: 383-9, 1970.
21. Piquet Y,Janvier G, Selosse P, Doutremepuich C, Jouneau J, Nicolle G, Platel D, Vezon G. Virus inactivation of fresh frozen plasma by a solvent detergent procedure: Biological results. Vox Sang 63: 251-6, 1992.
22. Remuzzi G, Ruggenenti P. The hemolytic uremic syndrome. Kidney Int 47: 2-19, 1995.
23. Rizvi MA, Vesely SK, George JN, Chandler L, Duvall D, Smith JW, Gilcher RO. Plasma exchange complications in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion 40: 896-901, 2000.
24. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA, and the Canadian Apheresis Group. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 325: 393-7, 1991.
25. Rock GA. Management of thrombotic thrombocytopenic purpura. Br J Haematol 109: 496-507, 2000.
26. Ruggenenti P, Galbusera M, Plata Cornejo R, Bellevita P, Remuzzi G. Thrombotic thrombocytopenic purpura: Evidence that infusion rather than plasma exchanges induces remission of the disease. Am J Kidney Dis 21: 314-8, 1993.
27. Ruggenenti P, Remuzzi G. The pathophysiology and management of thrombotic thrombocytopenic purpura. Eur J Haematol 56: 191-207, 1996.
28. Ruggenenti P, Noris M, Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int 60: 831-46, 2001.
29. Tsai H-M, Lian EC-Y. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339: 1585-94, 1998.
30. Tsai HM. High titers of inhibitors of von Willebrand factor-cleaving metalloproteinase in a fatal case of acute thrombotic thrombocytopenic purpura. Am J Hematol 65: 251-5, 2000.
31. Tsai HM, Li A, Rock G. Inhibitors of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura. Clin Lab 47: 387-92, 2001.
32. Veyradier A, Obert B, Houllier A, Meyer D, Girma JP. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: A study of 111 cases. Blood 98: 1765-72, 2001.
33. Wada H, Kaneko T, Ohiwa M, Tanigawa M, Hayashi T, Tamaki S, Minami N, Deguchi K, Suzuki K, Nakano T. Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura. Am J Hematol 44: 101-5, 1993.
34. Weening, JJ, van Guldener C, Daha MR, Klar N, van der Wal A, Prins FA. The pathophysiology of protein-overload proteinuria. Am J Pathol 129: 64-73, 1987.